The Potential for EBV Vaccines to Prevent Multiple Sclerosis
There is increasing evidence suggesting that Epstein-Barr virus infection is a causative factor of multiple sclerosis (MS). Epstein-Barr virus (EBV) is a human herpesvirus, Human Gammaherpesvirus 4. EBV infection shows two peaks: firstly, during early childhood and, secondly during the teenage years...
Main Authors: | Peter A. Maple, Alberto Ascherio, Jeffrey I. Cohen, Gary Cutter, Gavin Giovannoni, Claire Shannon-Lowe, Radu Tanasescu, Bruno Gran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.887794/full |
Similar Items
-
An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
by: Peter A. C. Maple, et al.
Published: (2020-08-01) -
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
by: Xinle Cui, et al.
Published: (2021-10-01) -
Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
by: Marija Rozman, et al.
Published: (2022-07-01) -
Progress in EBV Vaccines
by: Dwain G. van Zyl, et al.
Published: (2019-02-01) -
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective
by: Gabriela M. Escalante, et al.
Published: (2022-04-01)